The Next Frontier For GLP-1 Medications: Potential Therapy For Inflammation
GLP-1 medications like Ozempic and Wegovy, known for weight loss, are showing promise in treating inflammation and tissue damage, particularly in osteoarthritis. A study in Cell Metabolism found semaglutide reduced inflammation and pain independent of weight loss, though obesity exacerbates these conditions. Efforts are underway to improve access to these costly medications through initiatives like the Medicare GLP-1 Bridge program, aiming for broader insurance coverage and integration into standard benefits. AI
IMPACT New therapeutic applications for GLP-1 drugs could expand their market and impact patient care for inflammatory conditions.